Patent details

Basic Information

Publication number:

LUC50038

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP241735638

Legal Status:

Pending & Published

Application number:

LUC50038

First applicant's nationality:

Procedural language:

English

Marketing Authorization

Marketing Authorization Number:

EU/1/25/1962

Marketing Authorization Type:

Marketing Authorization Date:

19/08/2025

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

20/02/2026

First Marketing Authorization date:

19/08/2025

Grant date:

Activation date:

Publication date:

23/02/2026

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

17/09/2038

SPC Extension Expiration:

17/09/2038

Rejection date:

Withdrawal date:

Owner

From:

20/02/2026

 

 

Name:

F. Hoffmann-La Roche Ltd

Address:

Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Name:

Madrigal Pharmaceuticals, Inc.

Address:

200 Barr Harbor Drive Suite 200, West Conshohocken, PA 19428, United States (US)

Agent

Name:

Dennemeyer & Associates S.A.

From:

20/02/2026

Address:

55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)

To:

Publication

Bulletin

Bulletin Heading:

SPC1

Bulletin edition number:

2026/04

Publication date:

03/03/2026

Description:

Section C : Published requests for Supplementary Protection Certificates – I1 publication

Annual Fees

Annual Fee Due Date:

30/09/2033

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
23/02/2026	Outgoing Correspondence	1
20/02/2026	MA publication	12
20/02/2026	Marketing authorization	4
23/02/2026	Publication	1
20/02/2026	Application Form	5
20/02/2026	Outgoing Correspondence	2
20/02/2026	General Document	35
20/02/2026	General Document	1
20/02/2026	General Document	116